Silicon Laboratories (SLAB) Ratios
0 Followers
Silicon Laboratories Ratios
MX:SLAB's free cash flow for Q2 2026 was $-26.83M. For the 2026 fiscal year, MX:SLAB's free cash flow was decreased by $-12.32M and operating cash flow was $-14.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.69 | 6.15 | 4.51 | 7.87 | 3.35 |
| Quick Ratio | 4.02 | 5.07 | 3.32 | 7.33 | 3.27 |
| Cash Ratio | 2.53 | 2.88 | 1.39 | 2.69 | 1.61 |
| Solvency Ratio | -0.15 | -1.00 | 0.07 | 0.19 | 2.92 |
| Operating Cash Flow Ratio | 0.67 | -0.14 | -0.19 | 0.39 | -0.15 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -0.67 | 0.00 | -0.22 |
| Net Current Asset Value | $ 499.12M | $ 459.38M | $ 503.56M | $ 696.94M | $ 1.49B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.02 | 0.04 | 0.25 | 0.15 |
| Debt-to-Equity Ratio | 0.00 | 0.02 | 0.05 | 0.39 | 0.20 |
| Debt-to-Capital Ratio | 0.00 | 0.02 | 0.05 | 0.28 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.27 | 0.00 |
| Financial Leverage Ratio | 1.16 | 1.13 | 1.19 | 1.54 | 1.34 |
| Debt Service Coverage Ratio | -26.51 | -107.72 | 0.75 | 22.51 | 0.05 |
| Interest Coverage Ratio | -72.35 | -126.33 | -4.35 | 17.74 | -1.06 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.11 | 0.05 |
| Interest Debt Per Share | 0.03 | 0.71 | 2.21 | 15.80 | 11.25 |
| Net Debt to EBITDA | 19.32 | 2.48 | -3.53 | 0.25 | -17.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.23% | 53.42% | 58.88% | 62.74% | 59.01% |
| EBIT Margin | -7.26% | -26.27% | -0.64% | 13.00% | -3.77% |
| EBITDA Margin | -2.40% | -17.95% | 5.89% | 18.53% | 4.91% |
| Operating Profit Margin | -8.99% | -28.32% | -3.09% | 11.65% | -4.56% |
| Pretax Profit Margin | -7.38% | -26.49% | -3.40% | 12.68% | -6.17% |
| Net Profit Margin | -8.27% | -32.69% | -4.41% | 8.93% | 293.73% |
| Continuous Operations Profit Margin | -8.27% | -32.69% | -4.41% | 8.93% | -8.03% |
| Net Income Per EBT | 112.08% | 123.38% | 129.89% | 70.39% | -4763.87% |
| EBT Per EBIT | 82.10% | 93.55% | 110.01% | 108.88% | 135.35% |
| Return on Assets (ROA) | -5.11% | -15.62% | -2.39% | 4.21% | 71.57% |
| Return on Equity (ROE) | -5.93% | -17.69% | -2.86% | 6.51% | 95.70% |
| Return on Capital Employed (ROCE) | -6.27% | -14.71% | -1.89% | 6.01% | -1.43% |
| Return on Invested Capital (ROIC) | -6.27% | -14.64% | -1.82% | 4.23% | -1.20% |
| Return on Tangible Assets | -7.46% | -23.59% | -3.43% | 5.35% | 85.97% |
| Earnings Yield | -1.50% | -4.64% | -0.82% | 1.92% | 23.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.16 | 10.73 | 26.70 | 14.34 | 7.33 |
| Payables Turnover | 6.46 | 6.41 | 5.59 | 4.25 | 6.24 |
| Inventory Turnover | 3.43 | 2.58 | 1.66 | 3.80 | 5.99 |
| Fixed Asset Turnover | 6.10 | 4.42 | 5.36 | 6.74 | 4.92 |
| Asset Turnover | 0.62 | 0.48 | 0.54 | 0.47 | 0.24 |
| Working Capital Turnover Ratio | 1.52 | 1.08 | 0.85 | 0.72 | 0.64 |
| Cash Conversion Cycle | 79.95 | 118.76 | 168.89 | 35.56 | 52.23 |
| Days of Sales Outstanding | 30.01 | 34.03 | 13.67 | 25.46 | 49.78 |
| Days of Inventory Outstanding | 106.42 | 141.66 | 220.47 | 96.06 | 60.91 |
| Days of Payables Outstanding | 56.48 | 56.92 | 65.24 | 85.96 | 58.46 |
| Operating Cycle | 136.42 | 175.68 | 234.13 | 121.52 | 110.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.92 | -0.43 | -0.95 | 2.05 | -2.35 |
| Free Cash Flow Per Share | 2.01 | -0.80 | -1.65 | 1.29 | -3.01 |
| Dividend Paid and CapEx Coverage Ratio | 3.20 | -1.18 | -1.36 | 2.71 | -3.51 |
| Capital Expenditure Coverage Ratio | 3.20 | -1.18 | -1.36 | 2.71 | -3.51 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.65 | -0.47 | 0.13 | -0.22 |
| Operating Cash Flow to Sales Ratio | 0.12 | -0.02 | -0.04 | 0.07 | -0.14 |
| Free Cash Flow Yield | 1.52% | -0.62% | -1.25% | 0.95% | -1.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -66.63 | -21.55 | -121.88 | 52.08 | 4.18 |
| Price-to-Sales (P/S) Ratio | 5.50 | 7.04 | 5.38 | 4.65 | 12.26 |
| Price-to-Book (P/B) Ratio | 3.94 | 3.81 | 3.48 | 3.39 | 4.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 65.62 | -160.32 | -79.93 | 105.12 | -68.52 |
| Price-to-Operating Cash Flow Ratio | 45.10 | -295.71 | -138.62 | 66.29 | -88.02 |
| Price-to-Earnings Growth (PEG) Ratio | 1.00 | -0.05 | 0.86 | -0.55 | 0.00 |
| Enterprise Value Multiple | -209.67 | -36.73 | 87.74 | 25.33 | 232.03 |
| Enterprise Value | 3.95B | 3.85B | 4.04B | 4.81B | 8.22B |
| EV to EBITDA | -209.67 | -36.73 | 87.74 | 25.33 | 232.03 |
| EV to Sales | 5.04 | 6.59 | 5.17 | 4.69 | 11.40 |
| EV to Free Cash Flow | 60.08 | -150.17 | -76.84 | 106.17 | -63.69 |
| EV to Operating Cash Flow | 41.30 | -277.01 | -133.26 | 66.95 | -81.81 |
| Tangible Book Value Per Share | 21.24 | 20.72 | 24.30 | 26.90 | 40.09 |
| Shareholders’ Equity Per Share | 33.45 | 33.55 | 38.00 | 40.04 | 51.66 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.12 | -0.23 | -0.30 | 0.30 | -0.30 |
| Revenue Per Share | 23.98 | 18.15 | 24.60 | 29.19 | 16.83 |
| Net Income Per Share | -1.98 | -5.93 | -1.09 | 2.61 | 49.44 |
| Tax Burden | 1.12 | 1.23 | 1.30 | 0.70 | -47.64 |
| Interest Burden | 1.02 | 1.01 | 5.33 | 0.98 | 1.64 |
| Research & Development to Revenue | 0.45 | 0.57 | 0.43 | 0.32 | 0.38 |
| SG&A to Revenue | 0.22 | 0.25 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.10 | 0.11 | 0.06 | 0.06 | 0.08 |
| Income Quality | -1.47 | 0.07 | 0.88 | 0.79 | -0.05 |
Currency in USD
